Collard Craig A
- SEC CIK
- 0001363558
No open-market purchases or sales filed in the past year.
Current role at each company
- HRTX Heron Therapeutics, Inc.Chief Executive Officeras of Aug 3, 2026
- TSNDF TerrAscend Corp.Directoras of Jun 25, 2026
- OPNT Opiant Pharmaceuticals, Inc.Directoras of Mar 3, 2023
- SRRA Sierra Oncology, Inc.Directoras of Jul 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Collard Craig A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HRTX Heron Therapeutics, Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2023 (view filing) | Nov 16 | 1 day | Collard Craig AChief Executive Officer | PPurchase | +150.0K | $0.92 | +$138.0K | +411.0%186.5K after |
TSNDF TerrAscend Corp.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2022 (view filing) | Sep 23 | 4 days | Collard Craig ADirector | PPurchase | +60.0K | – | – | +16.6%420.9K after | |
| Sep 26, 2022 (view filing) | Sep 22 | 4 days | Collard Craig ADirector | PPurchase | +120.0K | – | – | +49.8%360.9K after |
OPNT Opiant Pharmaceuticals, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2022 (view filing) | Jun 10-13 | 3 days | Collard Craig ADirector | PPurchase | +5.70K | $11.10 | +$63.3K | +11.8%53.8K after | 2 lots |
| May 17, 2022 (view filing) | May 16 | 1 day | Collard Craig ADirector | PPurchase | +27.1K | $13.54 | +$367.6K | +129.5%48.1K after | |
| May 16, 2022 (view filing) | May 13 | 3 days | Collard Craig ADirector | PPurchase | +3.69K | $10.49 | +$38.7K | +21.3%21.0K after | |
| Sep 15, 2021 (view filing) | Sep 13 | 2 days | Collard Craig ADirector | PPurchase | +2.50K | $18.13 | +$45.3K | +18.4%16.1K after | |
| Sep 13, 2021 (view filing) | Sep 10 | 3 days | Collard Craig ADirector | PPurchase | +9.58K | $18.18 | +$174.1K | +239.4%13.6K after |
SRRA Sierra Oncology, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 (view filing) | Nov 23-24 | 1 day | Collard Craig ADirector | PPurchase | +13.5K | $23.03 | +$310.9K | New position13.5K after | 2 lots |